PepSight
WEIGHT MANAGEMENT

Tirzepatide (GLP-1/GIP)

Tirzepatide (GLP-1/GIP) is a weight management peptide used in evidence-based, physician-supervised protocols. Preferred over semaglutide when maximum weight loss is priority or semaglutide plateau is reached.

What is Tirzepatide (GLP-1/GIP)?

Dual GLP-1/GIP receptor agonist (twincretin). GIP activation amplifies GLP-1 effects on insulin secretion and adds direct adipocyte lipolysis via GIP receptors on fat cells. Produces superior weight loss vs. GLP-1 monotherapy (~20% SURMOUNT data). TITRATION: Start 2.5mg (25 units) x4 weeks → 5mg → 7.5mg → 10mg → 12.5mg → 15mg.

Uses & clinical decision logic

Preferred over semaglutide when maximum weight loss is priority or semaglutide plateau is reached.

Tirzepatide (GLP-1/GIP) dosage & administration

Vial sizeBAC waterDosing rangeUnits / doseFrequencyRoute
5mg0.5mL2.5-15mg (titrate)25-150 units1x/weekSubQ
10mg1mL2.5-15mg (titrate)25-150 units1x/weekSubQ
15mg1mL2.5-15mg (titrate)17-100 units1x/weekSubQ
30mg2mL2.5-15mg (titrate)17-100 units1x/weekSubQ
60mg2mL2.5-15mg (titrate)8-50 units1x/weekSubQ

Safety & contraindications

Same as GLP-1 class — MEN2, MTC, pancreatitis.

Stacking & combinations

Can add Cagrilintide, AOD-9604, or metabolic peptides. Do not combine with semaglutide.

Related peptides

Frequently asked questions

What is Tirzepatide (GLP-1/GIP) used for?

Preferred over semaglutide when maximum weight loss is priority or semaglutide plateau is reached.

What is the typical Tirzepatide (GLP-1/GIP) dosage?

Common dosing ranges from 2.5-15mg (titrate) (1x/week, SubQ). Exact dosing is individualized and set by a licensed physician.

How is Tirzepatide (GLP-1/GIP) administered?

Tirzepatide (GLP-1/GIP) is typically administered via SubQ.

What are the contraindications for Tirzepatide (GLP-1/GIP)?

Same as GLP-1 class — MEN2, MTC, pancreatitis.

Considering Tirzepatide (GLP-1/GIP)?

Build a physician-supervised protocol around your goal — no gatekeeping, real doctors, 503A compounding pharmacies.

Build your protocol →

This page is for educational purposes only and is not medical advice. Peptide therapies described here are provided under physician supervision through 503A compounding pharmacies. Many peptides are not FDA-approved for the uses described. Do not start, stop, or change any protocol without consulting a licensed physician.